Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
12/2005
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267126 Compounds derived from aryl carbamates, preparation thereof and uses of same
12/01/2005US20050267123 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
12/01/2005CA2567343A1 N-cyclic sulfonamido inhibitors of gamma secretase
12/01/2005CA2566934A1 Tetrahydronaphthyl- piperazines as 5-ht1b antagonists, inverse agonists and partial agonists
12/01/2005CA2566460A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use thereof
11/2005
11/30/2005EP1600442A1 Heteroarylcarbamoylbenzene derivative
11/30/2005EP1599449A2 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors
11/30/2005EP1599096A2 Hetero substitued sodium channel blockers
11/30/2005EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
11/30/2005CN1703221A 2-alkyl-(2-amino-3-aryl-propionyl)-piperazine derivatives and related compounds as melanocortin receptor ligands for the treatment of obesity
11/30/2005CN1701814A F1K-1 is a receptor for vascular endothelial growth factor
11/30/2005CN1229382C Hemisynthetic method and intermediate thereof
11/29/2005US6969715 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
11/29/2005US6969713 Piperidine and piperazine acetamide derivatives
11/24/2005US20050261503 Heteroaromatic glucokinase activators
11/24/2005US20050261499 Process for preparing (r)-aryloxypropionic acid ester derivatives
11/24/2005US20050261494 Process for synthesis of dinitrotetraoxadiazaisowurzitane (DTIW)
11/24/2005US20050261312 Pharmaceutically acceptable inorganic and organic salts of 5-methylpyrazine-2-carboxylic acid-4-oxide
11/24/2005US20050261311 Piperizinones as modulators of chemokine receptor activity
11/24/2005US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/24/2005US20050261291 1-Cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine or a salt or hydrate; exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action; for treating inflammatory diseases and autoimmune diseases such as inflammatory bowel diseases and rheumatoid arthritis
11/24/2005US20050261290 Novel compounds of proline and morpholine derivatives
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/24/2005US20050261244 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
11/24/2005US20050260597 Transfection reagents
11/24/2005US20050260130 Arylphosphonium compounds containing fluorine-18 that are useful as imaging agents; in particular, the phosphonium compound is a tetraaryl phosphonium salt, [F-18]-(4-fluorophenyl)triphenylphosphonium nitrate; Position Emission Tomography
11/23/2005EP1598359A1 Process for synthesis of dinitrotetraoxadiazisowursitane (DTIW)
11/23/2005EP1597322A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
11/23/2005EP1377550B9 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/23/2005CN1699367A Process for synthesis of dinitrotetraoxadiazaisowurzitane (dtiw)
11/23/2005CN1228331C Method for synthesizing cis-2,6-dimethyl piperazine
11/23/2005CN1228327C Carboxylic acid derivatives and drugs containing the same
11/22/2005US6967202 Attaching amino acid to a solid support, reacting with amino acid derivative to form a dipeptide attached to solid support; removing dipeptide from solid support; cyclizing the dipeptide to form a diketopiperazine
11/22/2005CA2187174C .alpha.-substituted phenylacetic acid derivative, process for producing the same, and agricultural bactericide containing the same
11/17/2005WO2005108404A1 Heavy metal complex of ethynyl group-substituted fused heterocyclic compound, method for producing same, synthetic intermediate thereof, method for producing same, and organic electroluminescent device
11/17/2005WO2005108391A1 Amides as bace inhibitors
11/17/2005WO2005108378A2 Use of (4-alkylpiperazinyl) (phenyl) methanones in the treatment of alzheimer’s disease
11/17/2005WO2005108359A1 Novel compounds of proline and morpholine derivatives
11/17/2005WO2005108358A2 Pyrrolidine derivatives useful as bace inhibitors
11/17/2005WO2005108347A2 Substituted enaminones, their derivatives and uses thereof
11/17/2005WO2005072361A3 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
11/17/2005WO2005034857A8 Methods and compositions comprising diamines as new anti-tubercular therapeutics
11/17/2005WO2005023204A3 Aromatic prodrugs of propofol, compositions and uses thereof
11/17/2005WO2005016264A3 Diamine derivatives of quinone and uses thereof
11/17/2005US20050256000 Quinoxalin-2-one derivatives, compositions which protect useful plants and comprise these derivatives, and processes for their preparation and their use
11/17/2005CA2565843A1 Novel compounds of proline and morpholine derivatives
11/17/2005CA2564068A1 Use of (4-alkylpiperazinyl) (phenyl) methanones in the treatment of alzheimer's disease
11/16/2005EP1595871A2 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
11/16/2005CN1696119A Method for preparing 2-quinoxaline alcohol
11/16/2005CN1696118A Microwave heating method for synthesizing quinxalines
11/16/2005CN1227237C Piperazinylpyrazines compounds as antagonists of serotonin-5-HT2 receptor
11/16/2005CN1227234C Substituted iminoazines
11/15/2005US6964965 Corticotropin releasing factor antagonists
11/10/2005WO2005105764A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005US20050250791 Process for preparing monoarylpiperazines
11/10/2005US20050250790 Novel sulfonic acid derivatives
11/10/2005US20050250768 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
11/10/2005CA2565184A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/09/2005EP1593671A1 DPP-IV inhibitors
11/09/2005EP1592389A2 Piperazine-2-carboxamide derivatives
11/09/2005EP1165576B1 Process for preparing amine platinum complexes
11/09/2005CN1694873A Vanilloid receptor ligands and their use in treatments
11/09/2005CN1226295C Preparation method of important intermediate for mosapride citrate
11/09/2005CN1226250C Anthracene derivatives and organic electroluminescent device made by using the same
11/08/2005US6962995 Phenanthroline derivatives
11/03/2005WO2005103030A1 1,4-di substituted benzene compounds, process for preparing the same and use thereof
11/03/2005WO2005102340A1 Piperazine melanocortin-specific compounds
11/03/2005WO2005044201A3 Ph sensitive prodrugs of 2,6-diisopropylphenol
11/03/2005US20050245551 Amide derivatives
11/03/2005US20050245542 Pyridazine, pyrimidine and pyrazine ethyne compounds
11/03/2005US20050245525 Compounds useful for inhibiting CHK1
11/02/2005EP1590321A2 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
11/01/2005US6960612 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/01/2005US6960575 Thiazine derivatives
11/01/2005US6960355 Modified amino acid compounds useful in delivery of active agents
10/2005
10/27/2005WO2005100334A1 Dipeptidyl peptidase-iv inhibitors
10/27/2005WO2005100325A1 Aryl glycinamide derivatives and their use as nk1 antagonists and serotonin reuptake inhibithors
10/27/2005WO2005100324A1 2- ( arylalkoxy ) -1- phenylethylamine derivatives as nk1 antagonist and serotonin reuptake inhibitors
10/27/2005US20050240060 Low loss high refractive index vinyl sulfide compounds and method of making same
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
10/27/2005US20050239887 Pharmaceutical composition that is used to control blood glucose in patients with type 2 diabetes
10/27/2005US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
10/27/2005US20050239803 Method for the preparation of 5-methylpyrazine-2-carboxylic acid-4-oxide and its salts
10/27/2005US20050239802 E.g., 6-{2-[5-Chloro-2-(2,4-difluorobenzyloxy)- phenyl]cyclopent-1-enyl}-pyridine-2-carboxylic acid, used to treat prostaglandin mediated diseases that include inflammatory, neuropathic or visceral pain
10/27/2005US20050239799 1-phenyl-4-benzylpiperazines dopamine receptor subtype
10/27/2005US20050236980 Charge transport compositions and electronic devices made with such compounds
10/26/2005EP1587796A1 Saturated quinoxaline derivatives and their use as metabotropic glutamate receptor ligands
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1289965B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/26/2005EP1098870B1 Nitrate salt of Cetirizine
10/26/2005CN1688547A A-'7-halo-2-quino (xa-) linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents
10/26/2005CN1688545A Phosphodiesterase 4 inhibitors, including n-substituted phenylamine and diphenylamine analogs
10/26/2005CN1687038A Method for producing Carbadox growth promoter for livestock and brids
10/26/2005CN1224619C Synthesizing method for D(-)-alpha-(4-ethyl-2, 3-bioxopiperazine-1-formamido )p-hydrophenylacetic acid
10/26/2005CN1224618C Process for preparing 1-methyl-3-substituted piperazine like compound
10/25/2005US6958333 N'-(isoindolino[3,2-b]perhydro-1,3-oxazin-5-on-9-yl)-N-(pyridin-2-yl) urea, for example; cyclin-dependent kinase inhibitors; colon cancer treatment
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/20/2005WO2005097779A1 Diarylamine derivatives as calcium channel blockers
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 187